Literature DB >> 27689204

Serendipity in Refractory Celiac Disease: Full Recovery of Duodenal Villi and Clinical Symptoms after Fecal Microbiota Transfer.

Yvette H van Beurden1, Tom van Gils2, Nienke A van Gils3, Zain Kassam4, Chris J J Mulder2, Nieves Aparicio-Pagés3.   

Abstract

Treatment of refractory celiac disease type II (RCD II) and preventing the development of an enteropathy associated T-cell lymphoma in these patients is still difficult. In this case report, we describe a patient with RCD II who received fecal microbiota transfer as treatment for a recurrent Clostridium difficile infection, and remarkably showed a full recovery of duodenal villi and disappearance of celiac symptoms. This case suggests that altering the gut microbiota may hold promise in improving the clinical and histological consequences of celiac disease and/or RCD II.

Entities:  

Mesh:

Year:  2016        PMID: 27689204     DOI: 10.15403/jgld.2014.1121.253.cel

Source DB:  PubMed          Journal:  J Gastrointestin Liver Dis        ISSN: 1841-8724            Impact factor:   2.008


  12 in total

Review 1.  Scaling Safe Access to Fecal Microbiota Transplantation: Past, Present, and Future.

Authors:  Ryan Eliott; Pratik Panchal; Shrish Budree; Alex Scheeler; Geraldine Medina; Monica Seng; Wing Fei Wong; Thomas Mitchell; Zain Kassam; Jessica R Allegretti; Majdi Osman
Journal:  Curr Gastroenterol Rep       Date:  2018-03-28

Review 2.  The role of the microbiome in cancer development and therapy.

Authors:  Aadra P Bhatt; Matthew R Redinbo; Scott J Bultman
Journal:  CA Cancer J Clin       Date:  2017-05-08       Impact factor: 508.702

3.  The costs of celiac disease: a contingent valuation in Switzerland.

Authors:  Laia Soler; Nicolas Borzykowski
Journal:  Eur J Health Econ       Date:  2021-10-07

Review 4.  Refractory Celiac Disease.

Authors:  Isabel A Hujoel; Joseph A Murray
Journal:  Curr Gastroenterol Rep       Date:  2020-03-17

5.  Refractory Celiac Disease Type II: A Case Report and Literature Review.

Authors:  Richa Chibbar; Jordan Nostedt; Dana Mihalicz; Jean Deschenes; Ross McLean; Levinus A Dieleman
Journal:  Front Med (Lausanne)       Date:  2020-12-03

6.  Refractory Celiac Disease Successfully Treated With Azathioprine.

Authors:  Umair Iqbal; Ahmad Chaudhary; Muhammad Arsalan Karim; Hafsa Anwar; Nancy Merrell
Journal:  Gastroenterology Res       Date:  2017-06-30

7.  Comparative Study of Salivary, Duodenal, and Fecal Microbiota Composition Across Adult Celiac Disease.

Authors:  Simona Panelli; Enrica Capelli; Giuseppe Francesco Damiano Lupo; Annalisa Schiepatti; Elena Betti; Elisabetta Sauta; Simone Marini; Riccardo Bellazzi; Alessandro Vanoli; Annamaria Pasi; Rosalia Cacciatore; Sara Bacchi; Barbara Balestra; Ornella Pastoris; Luca Frulloni; Gino Roberto Corazza; Federico Biagi; Rachele Ciccocioppo
Journal:  J Clin Med       Date:  2020-04-13       Impact factor: 4.241

Review 8.  Dietary Effects on Microbiota-New Trends with Gluten-Free or Paleo Diet.

Authors:  Yurdagül Zopf; Dejan Reljic; Walburga Dieterich
Journal:  Med Sci (Basel)       Date:  2018-10-18

Review 9.  Non-Responsive Coeliac Disease: A Comprehensive Review from the NHS England National Centre for Refractory Coeliac Disease.

Authors:  Hugo A Penny; Elisabeth M R Baggus; Anupam Rej; John A Snowden; David S Sanders
Journal:  Nutrients       Date:  2020-01-14       Impact factor: 5.717

Review 10.  Role of the gut microbiota in the pathogenesis of coeliac disease and potential therapeutic implications.

Authors:  Anthony K Akobeng; Parul Singh; Manoj Kumar; Souhaila Al Khodor
Journal:  Eur J Nutr       Date:  2020-07-10       Impact factor: 5.614

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.